Literature DB >> 23329283

[Infection rate and Streptococcus agalactiae serotypes in samples of infected neonates in the city of Campinas (São Paulo), Brazil].

Kateli Fiolo1, Cibele Esteves Zanardi, Marizete Salvadego, Carmem Silvia Bertuzzo, Eliana Amaral, Roseli Calil, Carlos Emilio Levy.   

Abstract

PURPOSE: To describe the epidemiological cases and microbiological profile of Streptococcus agalactiae serotypes isolated from infected newborns of a Women's Health Reference Centre of Campinas, São Paulo, Brazil.
METHODS: Cross-sectional laboratory survey conducted from January 2007 to December 2011. The newborns' strains, isolated from blood and cerebrospinal fluid samples, were screened by hemolysis on blood ágar plates, Gram stain, catalase test, CAMP test, hippurate hydrolysis or by microbiological automation: Vitek 2 BioMerieux®. They were typed by PCR, successively using specific primers for species and nine serotypes of S. agalactiae.
RESULTS: Seven blood samples, one cerebrospinal fluid sample and an ocular sample, were isolated from nine newborns with infections caused by S. agalactiae, including seven cases of early onset and two of late onset. Only one of these cases was positive for paired mother-child samples. Considering that 13,749 deliveries were performed during the study period, the incidence was 0.5 cases of GBS infections of early onset per 1 thousand live births (or 0.6 per 1 thousand, including two cases of late onset) with 1, 3, 2, zero and 3 cases (one early and two late onset cases), respectively, for the years from 2007 to 2011. It was possible to apply PCR to seven of nine samples, two each of serotypes Ia and V and three of serotype III, one from a newborn and the other two from a paired mother-child sample.
CONCLUSIONS: Although the sample was limited, the serotypes found are the most prevalent in the literature, but different from the other few Brazilian studies available, except for type Ia.

Entities:  

Mesh:

Year:  2012        PMID: 23329283     DOI: 10.1590/s0100-72032012001200003

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  6 in total

1.  Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.

Authors:  Maria del Pilar Crespo-Ortiz; Claudia Rocio Castañeda-Ramirez; Monica Recalde-Bolaños; Juan Diego Vélez-Londoño
Journal:  BMC Infect Dis       Date:  2014-08-03       Impact factor: 3.090

Review 2.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999

3.  Capsular genotype distribution of Group B Streptococcus colonization among at-risk pregnant women in Sao Paulo, Brazil.

Authors:  Renato de Ávila Kfouri; Antônio Carlos Campos Pignatari; Elisa Junko Ura Kusano; Talita Trevizani Rocchetti; Clara Lopes Fonseca; Lily Yin Weckx
Journal:  Braz J Infect Dis       Date:  2021-06-01       Impact factor: 3.257

4.  Group B streptococcus neonatal infection in an intensive care unit in Brazil: high fatality and missed opportunities for antibiotic prophylaxis.

Authors:  Marilia Lopes Bahia Evangelista; Felipe Teixeira de Mello Freitas
Journal:  Braz J Infect Dis       Date:  2014-08-29       Impact factor: 3.257

5.  Assessment of conventional PCR and real-time PCR compared to the gold standard method for screening Streptococcus agalactiae in pregnant women.

Authors:  Michele Berger Ferreira; Fernanda de-Paris; Rodrigo Minuto Paiva; Luciana de Souza Nunes
Journal:  Braz J Infect Dis       Date:  2018-11-22       Impact factor: 3.257

6.  Early-onset neonatal sepsis and the implementation of group B streptococcus prophylaxis in a Brazilian maternity hospital: a descriptive study.

Authors:  Felipe Teixeira de Mello Freitas; Gustavo Adolfo Sierra Romero
Journal:  Braz J Infect Dis       Date:  2016-11-19       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.